mAbxience EN2024-09-18T17:50:50+02:00

BIOPHARMACEUTICAL DEVELOPMENT

Experts in biologics, specialized in biosimilars

We are a leading vertically integrated biopharmaceuticals company, committed to improving patient access to treatments worldwide. Our in-house, core R&D competencies set us apart in the development of biosimilars and innovator biologics.

CDMO PLATFORM

End-to-end solutions to meet any manufacturing need

Thanks to our independent CDMO platform, we provide integrated services, adapted to your requirements: from research batches to commercial batches, big or small. We have over a decade of experience in the development and commercialization of biopharmaceuticals.

JOIN US!

Do you want to work at mAbxience?

WHAT’S NEW?

Catch up with our latest developments

mAbxience and Egis Enter Strategic License Agreement for Biosimilar Candidates in Key Central and Eastern European Markets

mAbxience and Egis Enter Strategic License Agreement for Biosimilar Candidates in Key Central and Eastern European Markets

Press releases|

The role of CDMOs in global healthcare advancements

The role of CDMOs in global healthcare advancements

News|

Single-use technology: how efficient is the present and future of biopharma manufacturing?

Go to Top